ERGIC3 Antikörper (C-Term)
Kurzübersicht für ERGIC3 Antikörper (C-Term) (ABIN7184887)
Target
Alle ERGIC3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Human, Maus
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human ERGIC-3.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB:1:500-1:2000, IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:20000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- ERGIC3 (ERGIC and Golgi 3 (ERGIC3))
-
Andere Bezeichnung
- ERGIC3
-
Hintergrund
- 2310015B14Rik antibody, AV318804 antibody, C20orf47 antibody, CGI 54 antibody, D2Ucla1 antibody, dJ477O4.2 antibody, DKFZp547A2190 antibody, Endoplasmic reticulum Golgi intermediate compartment protein 3 antibody, endoplasmic reticulum localized protein ERp43 antibody, Endoplasmic reticulum-Golgi intermediate compartment protein 3 antibody, ERGI3_HUMAN antibody, ERGIC and golgi 3 antibody, ergic3 antibody, ERV46 antibody, NY BR 84 antibody, PRO0989 antibody, RP23-220D12.2 antibody, RP3-477O4.1 antibody, SDBCAG84 antibody, Serologically defined breast cancer antigen 84 antibody, Serologically defined breast cancer antigen NY BR 84 antibody, Serologically defined breast cancer antigen NY-BR-84 antibody
-
UniProt
- Q9Y282
Target
-